No Data Yet
Shareholder class action investigations are scrutinizing Molina Healthcare's fiscal 2025 financial guidance and cost assumptions, particularly concerning its new $5 billion Florida Medicaid contract.
Fintech firm Fiserv has become the worst-performing stock in the S&P 500 for 2025, recording a 70% decline year-to-date due to a reduced revenue forecast and slowing merchant services growth.
Molina Healthcare's stock fell 42.1% over the past six months to $168.08 per share, a decline attributed to softer-than-expected quarterly results and slowing customer growth.
StockStory analysis highlights Molina Healthcare's (MOH) 19.3% annual revenue growth over five years, while cautioning against Masimo (MASI) for its 16.3% sales decline and CVS Health (CVS) for its 2.9% annual EPS drop.
Molina Healthcare of South Carolina has partnered with Aeroflow Health to offer virtual diabetes care and nutrition counseling to its Commercial and Medicare members, reflecting a strategic shift towards preventative and digital health solutions for chronic disease management.